Advancing RAS/RASopathy therapies: An NCI‐sponsored intramural and extramural collaboration for the study of RASopathies

Author:

Gross Andrea M.1,Frone Megan2,Gripp Karen W.3,Gelb Bruce D.45,Schoyer Lisa6ORCID,Schill Lisa6,Stronach Beth6,Biesecker Leslie G.7ORCID,Esposito Dominic8,Hernandez Edjay Ralph1,Legius Eric9,Loh Mignon L.10,Martin Staci1,Morrison Deborah K.11,Rauen Katherine A.12ORCID,Wolters Pamela L.1,Zand Dina13,McCormick Frank8,Savage Sharon A.2ORCID,Stewart Douglas R.2ORCID,Widemann Brigitte C.1,Yohe Marielle E.1ORCID

Affiliation:

1. Pediatric Oncology Branch, Center for Cancer ResearchNational Cancer Institute Bethesda Maryland

2. Clinical Genetics Branch, Division of Cancer Epidemiology and GeneticsNational Cancer Institute Rockville Maryland

3. Department of Genetics, Division of PediatricsAl duPont Hospital for Children Wilmington Delaware

4. Department of PediatricsMindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai New York New York

5. Department of Genetics and Genomic SciencesMindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai New York New York

6. RASopathies Network Altadena California

7. Medical Genomics and Metabolic Genetics BranchNational Human Genome Research Institute Bethesda Maryland

8. NCI RAS InitiativeFrederick National Laboratory for Cancer Research Frederick Maryland

9. Laboratory for Neurofibromatosis Research, Department of Human GeneticsKU Leuven University Hospital Leuven Belgium

10. Department of PediatricsBenioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco San Francisco California

11. Laboratory of Cell and Developmental SignalingCenter for Cancer Research, National Cancer Institute Frederick Maryland

12. Department of Pediatrics, Division of Genomic MedicineUniversity of California Davis Sacramento California

13. Center for Drug Evaluation and ResearchFood and Drug Administration Rockville Maryland

Publisher

Wiley

Subject

Genetics (clinical),Genetics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3